Suppressed expression of tubedown-1 in retinal neovascularization of proliferative diabetic retinopathy

Investigative Ophthalmology and Visual Science

Volumn 42, Issue 12, 2001, Pages 3000-3007

  Gendron, R L ^a   Good, W V ^a   Adams, L C ^a   Paradis, H ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; BASIC FIBROBLAST GROWTH FACTOR; COLLAGEN TYPE 4; ENTACTIN; INTEGRIN; LAMININ; PROTEIN TUBEDOWN 1; PROTEOHEPARAN SULFATE; SOMATOMEDIN C; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR; VON WILLEBRAND FACTOR;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; BASEMENT MEMBRANE; CELL CULTURE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC RETINOPATHY; ENDOTHELIUM; ENZYME ACTIVITY; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN ISOLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; RETINA BLOOD VESSEL; RETINA NEOVASCULARIZATION;

ACETYLTRANSFERASES; AGED; ANIMALS; BLOTTING, WESTERN; CAPILLARIES; CELLS, CULTURED; DIABETES MELLITUS, TYPE 1; DIABETIC RETINOPATHY; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MACACA MULATTA; MALE; MIDDLE AGED; RETINAL NEOVASCULARIZATION; RETINAL VESSELS;

EID: 0034754731     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Diabetic retinopathy
2. Diabetic retinopathy
3. Growth factors and diabetic retinopathy
4. Vascular endothelial growth factor and ocular neovascularization
5. Angiogenic factors in diabetic ocular disease: Mechanisms of today, therapies for tomorrow
6. Upregulation of the vascular endothelial growth factor/vascular endothelial growth factor receptor system in experimental background diabetic retinopathy of the rat
7. Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy
8. Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization
9. Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy
10. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins
11. Antagonists of integrin a-v b-3 inhibit retinal neovascularization in a murine model
12. Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor-type integrins inhibits retinal neovascularization
13. Tubedown-1, a novel acetyltransferase associated with blood vessel development
14. Co-distribution of von Willebrand factor and fibronectin in cultured rhesus endothelial cells
15. Specific antigen and organelle expression of a long-term rhesus endothelial cell line
16. Induction of embryonic vasculogenesis by bFGF and LIF in vitro and in vivo
17. 41/43 MAP kinase
18. Complete chromogen separation and analysis in double immunohistochemical stains using Photoshop-based image analysis
19. Vascular wall von Willebrand factor in human diabetic retinopathy
20. Relationship of polymorphonuclear leukocytes to capillary dropout in the human diabetic choroid
21. Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy
22. Cellular distribution of smooth muscle actins during mammalian embryogenesis: Expression of the alphavascular but not the gamma-enteric isoform in differentiating striated myocytes
23. Basic fibroblast growth factor and vascular endothelial growth factor are present in epiretinal and choroidal neovascular membranes
24. Expression of vitreous cytokines in proliferative vitreoretinopathy: A prospective study
25. Basic fibroblast growth factor levels in the vitreous of patients with proliferative diabetic retinopathy
26. Intravitreal growth factors in proliferative diabetic retinopathy: Correlation with neovascular activity and glycaemic management
27. Basement membrane abnormalities in human eyes with diabetic retinopathy
28. Identification of multiple active growth factors in basement membrane Matrigel suggests caution in interpretation of cellular activity related to extracellular matrix components
29. Isolation and characterization of type IV procollagen, laminin, and heparan sulfate proteoglycan from the EHS sarcoma
30. Pigment epitheliumderived factor: A potent inhibitor of angiogenesis
31. Unbalanced expression of VEGF and PEDF in ischemia-induced retinal neovascularization
32. Prevention of ischemia-induced retinopathy by the natural ocular antiangiogenic agent pigment epithelium-derived factor
33. Polymorphisms of the aldose reductase gene and susceptibility to retinopathy in type 1 diabetes mellitus
34. Bax is increased in the retina of diabetic subjects and is associated with pericyte apoptosis in vivo and in vitro
35. Identification and characterization of genes and mutants for an N-terminal acetyltransferase from yeast
36. The yeast ARD1 gene product is required for repression of cryptic mating-type information at the HML locus
37. ARD1 and NAT1 proteins form a complex that has N terminal acetyltransferase activity
38. Modifiers of position effect are shared between telomeric and silent mating-type loci in S. cerevisiae